AI-discovered lung disease drug shows potential to slow biological aging
Rentosertib, an AI-developed drug for idiopathic pulmonary fibrosis, made patients appear three to four years biologically younger in clinical trials.
Results for "Rentosertib"
2 stories found
AI-Developed Drug Reverses Biological Age in Clinical Trial
An experimental drug developed from scratch by AI algorithms, Rentosertib, reduced the biological age of patients with a rare lung disease by 3-4 years in a study published in Nature Biotechnology.